Elizabethkingia bloodstream infections in severely immunocompromised patients: persistent, relapsing and associated with high mortality.

IF 3.7 Q2 INFECTIOUS DISEASES JAC-Antimicrobial Resistance Pub Date : 2024-10-25 eCollection Date: 2024-10-01 DOI:10.1093/jacamr/dlae161
Mark Fahmy, Adam Stewart, Siok-Keen Tey, Krispin Hajkowicz
{"title":"<i>Elizabethkingia</i> bloodstream infections in severely immunocompromised patients: persistent, relapsing and associated with high mortality.","authors":"Mark Fahmy, Adam Stewart, Siok-Keen Tey, Krispin Hajkowicz","doi":"10.1093/jacamr/dlae161","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong><i>Elizabethkingia</i> species are uncommon causes of bloodstream infections, representing a true opportunistic and multi-drug-resistant pathogen to immunocompromised or vulnerable hosts. Despite this, data are lacking regarding optimal management strategy for infections with this organism, which is associated with significant mortality and morbidity. We describe patient characteristics, management and outcomes in this case series.</p><p><strong>Patients and methods: </strong>All inpatients at the Royal Brisbane and Women's Hospital with a positive blood culture for <i>Elizabethkingia</i> spp. were identified by database query. Clinical information including medical history, source of infection, attempts at source control and outcome were collected. Laboratory data including duration of bacteraemia and antimicrobial susceptibility testing were also collected.</p><p><strong>Results: </strong>All patients had severe defects of innate and adaptive immunity. Targeted therapy was started promptly and efforts at source identification and control were appropriately pursued. Despite this, outcomes were generally poor. A previously unrecognized presentation of relapsing infection was described in one case, requiring long-term suppressive antimicrobials to control. One case died as a result of infection and one case was cured, but died soon after due to complications of immunosuppression.</p><p><strong>Conclusions: </strong>Treatment of these organisms is challenging due to limited effective therapy, development of on treatment resistance and profound host immunocompromise. Up-front use of multiple, optimally dosed antimicrobials, attempting source control and attempting to restore host immune function all appear to be key to achieving good outcomes.</p>","PeriodicalId":14594,"journal":{"name":"JAC-Antimicrobial Resistance","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11523632/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAC-Antimicrobial Resistance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jacamr/dlae161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Elizabethkingia species are uncommon causes of bloodstream infections, representing a true opportunistic and multi-drug-resistant pathogen to immunocompromised or vulnerable hosts. Despite this, data are lacking regarding optimal management strategy for infections with this organism, which is associated with significant mortality and morbidity. We describe patient characteristics, management and outcomes in this case series.

Patients and methods: All inpatients at the Royal Brisbane and Women's Hospital with a positive blood culture for Elizabethkingia spp. were identified by database query. Clinical information including medical history, source of infection, attempts at source control and outcome were collected. Laboratory data including duration of bacteraemia and antimicrobial susceptibility testing were also collected.

Results: All patients had severe defects of innate and adaptive immunity. Targeted therapy was started promptly and efforts at source identification and control were appropriately pursued. Despite this, outcomes were generally poor. A previously unrecognized presentation of relapsing infection was described in one case, requiring long-term suppressive antimicrobials to control. One case died as a result of infection and one case was cured, but died soon after due to complications of immunosuppression.

Conclusions: Treatment of these organisms is challenging due to limited effective therapy, development of on treatment resistance and profound host immunocompromise. Up-front use of multiple, optimally dosed antimicrobials, attempting source control and attempting to restore host immune function all appear to be key to achieving good outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
严重免疫力低下患者的伊丽莎白金丝菌血流感染:持续、复发且死亡率高。
目的:伊丽莎白金丝菌是引起血流感染的罕见病原体,是免疫力低下或易感宿主的真正机会性和多重耐药病原体。尽管如此,目前仍缺乏有关该病原体感染的最佳管理策略的数据,该病原体感染会导致严重的死亡率和发病率。我们描述了该系列病例中患者的特征、管理和结果:通过数据库查询,确定了布里斯班皇家妇女医院所有伊丽莎白金格氏菌血液培养呈阳性的住院患者。收集的临床信息包括病史、感染源、控制感染源的尝试和结果。此外,还收集了包括菌血症持续时间和抗菌药敏感性测试在内的实验室数据:结果:所有患者的先天性免疫和适应性免疫均存在严重缺陷。结果:所有患者都存在严重的先天性和适应性免疫缺陷,均已及时开始针对性治疗,并采取了适当的病源识别和控制措施。尽管如此,治疗效果普遍不佳。其中一个病例出现了以前未曾发现的复发性感染,需要长期服用抗菌药物才能控制病情。一个病例因感染而死亡,一个病例虽然治愈,但不久后因免疫抑制并发症而死亡:结论:由于有效疗法有限、耐药性的产生以及宿主免疫功能极度低下,治疗这些病菌具有挑战性。前期使用多种剂量最佳的抗菌药物、尝试源头控制和尝试恢复宿主免疫功能似乎都是取得良好疗效的关键。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.30
自引率
0.00%
发文量
0
审稿时长
16 weeks
期刊最新文献
Outcomes of Enterococcus faecalis infective endocarditis according to MIC of amoxicillin: a multicentric study. Experience with expanded use of oritavancin in a tertiary hospital: indications, tolerability and outcomes. Antimicrobial use in hospitalized patients: a point prevalence survey across four tertiary hospitals in Niger. Aetiology, susceptibility and outcomes of fever in patients receiving chemotherapy in Malawi: a prospective study. Community pharmacists' knowledge and practices towards antimicrobial stewardship: findings and implications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1